CMTM4 can stabilize the surface expression of PD-L1 in HCC and intrahepatic cholangiocarcinoma (ICC) cell lines through preventing PD-L1 from endosome-lysosomal and proteasomal degradation [43]. Here, CD274 is linked to intrahepatic cholangiocarcinoma.